HHS, DoL, and the Treasury jointly issued FAQs regarding health coverage issues related to COVID-19. The guidance clarifies several key policies regarding group health plan and health insurance issuer COVID-19 testing coverage requirements, including:• The circumstances under which plans are and are not required to cover COVID-19 testing, clarifying for example that plans are not required to cover return-to-work or surveillance testing and are only required to cover items and services for diagnostic purposes;• The types of testing that must be covered, clarifying for example that at-home testing must be covered (provided such testing meets other coverage requirements described in the guidance);• The amount of testing that must be covered, clarifying for example that, if an individual receives multiple diagnostic tests, all tests must be covered; and• Billing and reimbursement policies, such as plans’ obligation to cover facility fees related to administration of a COVID-19 test or evaluation of an individual to determine their need for testing; and how to determine the reimbursement rate for providers of COVID-19 testing if the provider is not in-network with the plan.